Growth Metrics

Zymeworks (ZYME) Cash from Financing Activities (2021 - 2026)

Zymeworks recorded quarterly Cash from Financing Activities of $178.8 million in Q1 2026, up 1053.93% quarter-over-quarter from -$18.7 million in Q4 2025, and up 13485.56% year-over-year from N/an in Q1 2025.

Zymeworks' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $178.8 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 13485.56% year-over-year to $178.8 million; the TTM figure through Mar 2026 stood at $158.9 million (up 847.78% YoY), while the FY2025 annual figure was -$18.6 million, up 9.19% from the prior year.
  • Cash from Financing Activities came in at $178.8 million for Q1 2026 at Zymeworks, up from -$18.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $178.8 million in Q1 2026 to a low of -$18.7 million in Q4 2025.
  • A 5-year average of $19.4 million and a median of $1.3 million in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 13530.24% in 2023 and sank 889.87% in 2024, its largest moves.
  • Zymeworks' Cash from Financing Activities stood at -$377000.0 in 2022, then soared by 13530.24% to $50.6 million in 2023, then plunged by 117.07% to -$8.6 million in 2024, then slumped by 116.87% to -$18.7 million in 2025, then jumped by 1053.93% to $178.8 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $178.8 million, -$18.7 million, and -$2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 Zymeworks 1.84 Bn 1.47 Bn - 178.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 178.79 Mn
Mar 31, 2026 178.79 Mn
Dec 31, 2025 -18.74 Mn
Dec 31, 2025 -18.74 Mn
Sep 30, 2025 -2.45 Mn
Sep 30, 2025 -2.45 Mn
Jun 30, 2025 1.32 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.32 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 -8.64 Mn
Dec 31, 2024 -8.64 Mn
Sep 30, 2024 -14.98 Mn
Sep 30, 2024 -14.98 Mn
Jun 30, 2024 1.05 Mn
Jun 30, 2024 1.05 Mn
Mar 31, 2024 2.13 Mn
Mar 31, 2024 2.13 Mn
Dec 31, 2023 50.63 Mn
Dec 31, 2023 50.63 Mn
Sep 30, 2023 1.90 Mn
Sep 30, 2023 1.90 Mn
Jun 30, 2023 27.60 Mn
Jun 30, 2023 27.60 Mn
Mar 31, 2023 1.74 Mn
Mar 31, 2023 1.74 Mn
Dec 31, 2022 -377,000.00
Dec 31, 2022 -377,000.00
Sep 30, 2022 628,000.00
Sep 30, 2022 628,000.00
Jun 30, 2022 -279,000.00
Jun 30, 2022 -279,000.00
Mar 31, 2022 108.61 Mn
Mar 31, 2022 108.61 Mn
Dec 31, 2021 689,000.00
Dec 31, 2021 689,000.00